Medicine and Dentistry
Patient
100%
Silo-Filler's Disease
68%
Meta-Analysis
51%
Mycobacterium abscessus
43%
Inpatient
35%
Acute Respiratory Distress Syndrome
34%
Association
30%
Idiopathic Pulmonary Fibrosis
25%
Chronic Obstructive Pulmonary Disease
25%
Macrolide
18%
COVID-19
17%
Amikacin
17%
Pneumonia
17%
Diffuse Alveolar Damage
17%
Mycobacterium Avium Complex
17%
Lung Biopsy
17%
Chlorhexidine
17%
Endobronchial Ultrasonography
17%
Transbronchial Aspiration
17%
Diagnosis
17%
Hospital
15%
Culture
15%
Chest
13%
Interstitial Lung Disease
13%
Analysis
13%
Mortality
12%
Adverse Event
11%
Sputum Culture
11%
Computer Assisted Tomography
11%
Culture Conversion
11%
Combination Therapy
10%
Incidence
9%
Follow up
9%
Lung
9%
Clarithromycin
9%
Prognosis
9%
Antibiotics
8%
Long Term Exposure
8%
Respiratory System
8%
Lung Function
8%
Hyperinflation
8%
Cohort Analysis
8%
Bronchoscopy
8%
Prevalence
8%
Total Lung Capacity
8%
COVID-19 Vaccine
8%
Mycobacterium massiliense
8%
Rapid Response Team
8%
Endovascular Coiling
8%
Morphology
8%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
25%
Lung Disease
25%
Pneumonia
18%
Mycobacterium Avium Complex
17%
Macrolide
17%
Fibrosing Alveolitis
17%
Mortality
10%
Adverse Event
9%
Incidence
8%
Diseases
8%
Antibiotics
8%
Coronavirinae
8%
Beta Adrenergic Receptor Stimulating Agent
8%
Dexamethasone
8%
Mycobacterium abscessus
8%
Long Term Exposure
8%
Interstitial Lung Disease
8%
Gallium 68
8%
Lung Infection
8%
Statin (Protein)
8%
Corticosteroid
7%
Muscarinic Receptor Blocking Agent
7%
Amikacin
6%
Drug
5%
Clarithromycin
5%
Antibiotic Agent
5%
Nursing and Health Professions
Adult Respiratory Distress Syndrome
17%
Lung Disease
17%
Macrolide
17%
Meta Analysis
17%
Treatment Outcome
17%
Clinical Outcome
10%
Adverse Event
9%
Confidence Interval
9%
Oxygenation
9%
Cohort Analysis
8%
Compliance
8%
Length of Stay
8%
Rapid Response Team
8%
Hospital
8%
Patient
6%
Combination Therapy
5%